Clinical Trials Browser

Phase 1 × UNKNOWN × Clear all

NCT05499715 2022-08-12

A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors

Phase 1 Unknown

48 enrolled

Advanced Tumor of Digestive Tract or Urinary System

NCT02346955 2020-08-27

MK-6018-001

Phase 1 Terminated

27 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Clinical Trials

A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors

MK-6018-001

PICARES

GR1405 Injection in Patients With Advanced Solid Tumor or Lymphoma

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer

Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma

A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors

Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer

Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients

Phase 1 Trial of Chlorogenic Acid in Patients With Advanced Cancer

A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer

Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients